Skip to content
2000
Volume 14, Issue 2
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

The subject of chemosystematics has provided insight to both botanical classification and drug development. However, degrees of subjectivity in botanical classifications and limited understanding of the evolution of chemical characters and their biosynthetic pathways has often hampered such studies. In this review an approach of taking phylogenetic classification into account in evaluating colchicine and related phenethylisoquinoline alkaloids from the family Colchicaceae will be applied. Following on the trends of utilizing evolutionary reasoning in inferring mechanisms in eg. drug resistance in cancer and infections, this will exemplify how thinking about evolution can influence selection of plant material in drug lead discovery, and how knowledge about phylogenetic relationships may be used to evaluate predicted biosynthetic pathways.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/1568026613666131216110417
2014-01-01
2025-09-06
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/1568026613666131216110417
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test